Biomarkers for assessing rheumatoid arthritis disease activity

摘要

The present invention relates to a pharmaceutical composition for the treatment of rheumatoid arthritis, which comprises an agent for measuring the concentration of one or more proteins selected from the group consisting of sCD14 (soluble CD14), a-1-acid glycoprotein 1 and AGP2 And a composition for evaluating the activity of arthritis. The present invention also relates to a method for providing information for evaluating kit, protein chip and rheumatoid arthritis activity using the composition.;